Patents Assigned to InventisBio LLC
  • Heteroaryl compounds, preparation methods and uses thereof
    Patent number: 12492184
    Abstract: Provided herein are novel compounds, for example, compounds having a Formula (I), or a pharmaceutically acceptable salt thereof. Also provided herein are methods of preparing the compounds and methods of using the compounds, for example, in inhibiting TYK2, and/or function of IL-12, IL-23 and/or INF-alpha, and/or in treating various associated diseases or disorders.
    Type: Grant
    Filed: December 22, 2021
    Date of Patent: December 9, 2025
    Assignees: InventisBio Co., Ltd., InventisBio LLC
    Inventor: Xing Dai
  • Selective estrogen receptor degraders and uses thereof
    Patent number: 12187736
    Abstract: The present disclosure provides compounds of Formula (I) and Formula (II). The compounds described herein may be useful in treating proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
    Type: Grant
    Filed: July 11, 2023
    Date of Patent: January 7, 2025
    Assignee: InventisBio LLC
    Inventors: Xing Dai, Yaolin Wang
  • Inhibitor of indoleamine-2,3-dioxygenase (IDO)
    Patent number: 11969425
    Abstract: The present disclosure provides compounds of Formula (I). The compounds described herein may be useful in treating a disease associated with IDO, for example, cancer or an infectious disease (e.g., viral or bacterial infectious diseases). Also, provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
    Type: Grant
    Filed: February 9, 2023
    Date of Patent: April 30, 2024
    Assignee: INVENTISBIO LLC
    Inventors: Xing Dai, Yaolin Wang
  • HETEROARYL COMPOUNDS, SOLID FORMS, PREPARATION METHODS AND USES THEREOF
    Publication number: 20240025876
    Abstract: Provided herein are compounds, crystalline free forms, crystalline salt forms, and pharmaceutical compositions of Compound 1. Also provided are methods of preparing and methods of using the same, e.g., for inhibiting a kinase and/or for treating various diseases or disorders, such as autoimmune diseases.
    Type: Application
    Filed: June 20, 2023
    Publication date: January 25, 2024
    Applicants: InventisBio Co., Ltd., InventisBio LLC
    Inventors: Wei LI, Yanqin LIU, Dongmei QIANG, Xiaojun WANG, Xing DAI
  • Selective estrogen receptor degraders and uses thereof
    Patent number: 11014936
    Abstract: The present disclosure provides compounds of Formula (I) and Formula (II). The compounds described herein may be useful in treating proliferative diseases (e.g., cancer). Also provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
    Type: Grant
    Filed: October 17, 2019
    Date of Patent: May 25, 2021
    Assignee: INVENTISBIO LLC
    Inventors: Xing Dai, Yaolin Wang
  • Inhibitor of indoleamine-2,3-dioxygenase (IDO)
    Patent number: 10980807
    Abstract: The present disclosure provides compounds of Formula (I). The compounds described herein may be useful in treating a disease associated with IDO, for example, cancer or an infectious disease (e.g., viral or bacterial infectious diseases). Also, provided in the present disclosure are pharmaceutical compositions, kits, methods, and uses including or using a compound described herein.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: April 20, 2021
    Assignee: InventisBio LLC
    Inventors: Xing Dai, Yaolin Wang